Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/01/2007WO2007087424A3 Method of treating kcnq related disorders using organozinc compounds
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2007085775A3 Use of 15-lipoxygenase inhibitors for treating obesity
11/01/2007WO2007083096A3 N- (2, 3-difluorophenyl) -2- [4- ( {7-methoxy-5- [ (2r) -piperidin. -2-ylmethoxy] quinazoli n-4-yl}amino) -lh-pyrazol-1-yl] acetamide and n- (2, 3 -d i fluoro phenyl) -2- [4- ( {7-ethoxy-5- [ (2r) -piperidin. -2-ylmethoxy] quinazolin
11/01/2007WO2007082561A3 Method for the treatment of tinnitus
11/01/2007WO2007081755A3 Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
11/01/2007WO2007081694A3 Derivatives of sulindac, use thereof and preparation thereof
11/01/2007WO2007080560A3 The use of the process of induction of de novo synthesis of p-glycoprotein (p-gp) in the treatment of xenobiotic-induced intoxications in mammals
11/01/2007WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007076348A3 Azaindole inhibitors of aurora kinases
11/01/2007WO2007076260A3 Farnesoid x receptor agonists
11/01/2007WO2007075858A3 Novel forms of tiotropium bromide and processes for preparation thereof
11/01/2007WO2007075680A3 System and method for delivering a desired material to a cell
11/01/2007WO2007075598A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007072169A3 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
11/01/2007WO2007072147A3 Composition for diagnosing and treating circulatory system diseases
11/01/2007WO2007072092A3 New phenanthridine derivatives as bradykinin antagonists
11/01/2007WO2007071012A8 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
11/01/2007WO2007070840A3 Modified and pulsatile release pharmaceutical formulations of escitalopram
11/01/2007WO2007070319A3 Dibenzonaphthyridine derivatives and methods of use thereof
11/01/2007WO2007068815A3 Heterocyclic derivatives, preparation and therapeutic use thereof
11/01/2007WO2007067617A3 Use of a cb1 antagonist for treating negative symptoms of schizophrenia
11/01/2007WO2007066232A3 Salts of fatty acids and methods of making and using thereof
11/01/2007WO2007066192A3 Method for weight reduction
11/01/2007WO2007064853A3 Locked nucleic acid oligonucleotides
11/01/2007WO2007062542A3 Process for the manufacture of epoxybutanol intermediates
11/01/2007WO2007062376A3 Selective inhibition of matrix metalloproteinases
11/01/2007WO2007062288A3 Chemical synthesis of a highly potent epothilone
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007WO2007059905A9 Thienopyrimidines treating inflammatory diseases
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2007059008A3 N-substituted indenoisoquinolines and syntheses thereof
11/01/2007WO2007057768A3 Sulfonyl derivatives
11/01/2007WO2007056625A3 Thienopyridine b-raf kinase inhibitors
11/01/2007WO2007053844A3 Compositions and methods for treating inflammatory disorders
11/01/2007WO2007053193A3 Unsolvated benzodiazepine compositions and methods
11/01/2007WO2007046699A3 Method for stimulating intestinal barrier integrity after non-natural birth
11/01/2007WO2007041681A3 Methods for treating respiratory disorders
11/01/2007WO2007039177B1 Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
11/01/2007WO2007033023A3 Compositions and methods for the diagnosis and therapy of bcl2-associated cancers
11/01/2007WO2007030589A3 Pharmaceutical dosage forms and compositions comprising lecoztan
11/01/2007WO2007028135A3 Imidazopyridine compounds
11/01/2007WO2007027878A3 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
11/01/2007WO2007025178A3 Rolyvalent multimeric compositions containing active polypeptides, pharmaceutical compositions and methods of using the same
11/01/2007WO2007022385A3 Use of cxcr4 binding molecules for the treatment of whim syndrome
11/01/2007WO2007022371A3 Chemokine receptor binding compounds
11/01/2007WO2007022257A3 Monocyclic and bicyclic compounds and methods of use
11/01/2007WO2007019191A3 Thiazolopyrimidine kinase inhibitors
11/01/2007WO2007017436A3 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts
11/01/2007WO2007012019A3 Medicaments containing famotidine and ibuprofen and administration of same
11/01/2007WO2007011905A3 Lpa2 receptor agonist inhibitors of cftr
11/01/2007WO2007011743A3 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
11/01/2007WO2007001684A3 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents
11/01/2007WO2006136454A3 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease
11/01/2007WO2006131326B1 Novel use of (-)-epigallocatechin gallate
11/01/2007WO2006130879A3 Uses of prostacyclin analogs
11/01/2007WO2006127426A3 Insecticidal substituted benzylamino heterocyclic and heteroaryl derivatives
11/01/2007WO2006116057A3 Facilitated transport of bisphosphonates by vitamin c
11/01/2007WO2006113509B1 Quinobenzoxazine analogs and methods of using thereof
11/01/2007WO2006107949A3 Methods of protection from oxidative stress
11/01/2007WO2006103399A8 Hiv integrase inhibitors
11/01/2007WO2006102283A3 Beta-lactamylalkanoic acids for treating premenstrual disorders
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007WO2006092507A8 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/01/2007WO2006081515A3 Duloxetine hydrochloride polymorphs
11/01/2007WO2006062434A8 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations
11/01/2007WO2006050414A3 Antisense antiviral compounds and methods for treating filovirus infection
11/01/2007WO2005025490A3 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140
11/01/2007WO2005007672A8 Small molecule toll-like receptor (tlr) antagonists
11/01/2007WO2005004795A3 Compositions and methods for targeted drug delivery
11/01/2007WO2005000402A3 Anti-adhesion composites and methods os use thereof
11/01/2007WO2004062610A3 4',4''-SUBSTITUTED 3α-(DIPHENYLMETHOXY)TROPANE ANALOGS FOR TREATMENT OF MENTAL DISORDERS
11/01/2007WO2003084499A3 Gel cleaning preparations comprising pre-gelatinised, cross-linked starch derivatives and polyacrylates
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007WO2002079435A3 Transgenic mice containing gpcr-like gene disruptions
11/01/2007WO2002060471A3 Ligands for receptor-like protein tyrosine phosphatases
11/01/2007US20070255238 Hemostatic Polymer Useful for Rapid Blood Coagulation and Hemostasis
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070255062 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007US20070255059 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254963 Ozonidzed Pharmaceutical Composition and Method
11/01/2007US20070254962 Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
11/01/2007US20070254961 Polyisoprenylated Benzophenones and Their Isomers as Inhibitors of Histone Acetyltransferases and Uses thereof
11/01/2007US20070254960 Paracetamol and tapentadol; synergistic pain relief of cancer pain, migraines, neuropathic pain
11/01/2007US20070254959 Oxidizing 3-(2-methoxy-5-methylphenyl)-3-phenylpropanol to produce 3-(2-methoxy-5-methylphenyl)-3-phenylpropanal, reacting with diisopropylamine in presence of a reducing agent, removing hydroxyl protecting group to obtain for obtaining 3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropylamine
11/01/2007US20070254958 by preventing the formation of insoluble beta-amyloid and arresting the production of beta-amyloid; e.g. 3-{2-[(5-aminopentyl)amino]-2-oxoethoxy}-5-({[(1R)-1-(4-fluorophenyl)ethyl]amino}carbonyl)phenyl phenylmethanesulfonate
11/01/2007US20070254957 Triaryl compounds and derivates thereof
11/01/2007US20070254956 Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
11/01/2007US20070254955 Nail softener for use in deformed-nail corrective treatment or nail-structure modification, enclosure for external chemicals and method of correcting deformed nail
11/01/2007US20070254954 Composition with Preventive or Improvement Effect on Symptoms or Disesases Associted with Stress-Induced Behavior Disorders
11/01/2007US20070254953 Topical compositions of urea and ammonium lactate
11/01/2007US20070254952 Cannabinoid receptor modulators
11/01/2007US20070254950 Oculoselective Drugs and Prodrugs
11/01/2007US20070254948 Lipase Inhibitors
11/01/2007US20070254947 Composition for external use
11/01/2007US20070254946 Hair Growth Stimulants
1 ... 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 ... 7860